Study finds J&J vaccine has an efficacy of up to 71% against hospitalization from the highly contagious strain. Read Article
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/10/wsj.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-08-06 09:30:142021-08-09 09:31:11J&J Vaccine Highly Effective Against Delta Variant in South African Trial
